[go: up one dir, main page]

WO2012099420A3 - Composition et aliment fonctionnel comprenant des extraits d'élécampane et destinés au traitement du cancer du cerveau - Google Patents

Composition et aliment fonctionnel comprenant des extraits d'élécampane et destinés au traitement du cancer du cerveau Download PDF

Info

Publication number
WO2012099420A3
WO2012099420A3 PCT/KR2012/000502 KR2012000502W WO2012099420A3 WO 2012099420 A3 WO2012099420 A3 WO 2012099420A3 KR 2012000502 W KR2012000502 W KR 2012000502W WO 2012099420 A3 WO2012099420 A3 WO 2012099420A3
Authority
WO
WIPO (PCT)
Prior art keywords
brain cancer
elecampane
composition
extracts
treating brain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2012/000502
Other languages
English (en)
Korean (ko)
Other versions
WO2012099420A2 (fr
Inventor
황성연
정경채
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KOREA BIO MEDICAL SCIENCE INSTITUTE
Original Assignee
KOREA BIO MEDICAL SCIENCE INSTITUTE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KOREA BIO MEDICAL SCIENCE INSTITUTE filed Critical KOREA BIO MEDICAL SCIENCE INSTITUTE
Publication of WO2012099420A2 publication Critical patent/WO2012099420A2/fr
Publication of WO2012099420A3 publication Critical patent/WO2012099420A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/289—Vladimiria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Medicinal Chemistry (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

L'invention concerne une nouvelle utilisation d'extraits d'élécampane. Elle concerne plus particulièrement une composition destinée à la prévention et au traitement du cancer du cerveau, qui contient, comme principes actifs, des extraits d'éthanol provenant d'élécampane. L'invention concerne également un aliment fonctionnel destiné à la prévention du cancer du cerveau, qui comprend des additifs alimentaires cytologiquement acceptables, et contient, comme principes actifs, des extraits d'éthanol provenant d'élécampane. Selon l'invention, la composition et l'aliment fonctionnel destinés au traitement du cancer du cerveau peuvent avoir comme effets d'inhiber la croissance des cellules cancéreuses du cerveau et d'induire l'apoptose, et peuvent donc être utilisés efficacement dans le traitement ou la prévention du cancer du cerveau.
PCT/KR2012/000502 2011-01-19 2012-01-19 Composition et aliment fonctionnel comprenant des extraits d'élécampane et destinés au traitement du cancer du cerveau Ceased WO2012099420A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020110005457A KR20120084117A (ko) 2011-01-19 2011-01-19 목향 추출물을 포함하는 뇌암 치료용 조성물 및 건강 기능성 식품
KR10-2011-0005457 2011-01-19

Publications (2)

Publication Number Publication Date
WO2012099420A2 WO2012099420A2 (fr) 2012-07-26
WO2012099420A3 true WO2012099420A3 (fr) 2012-12-06

Family

ID=46516253

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/000502 Ceased WO2012099420A2 (fr) 2011-01-19 2012-01-19 Composition et aliment fonctionnel comprenant des extraits d'élécampane et destinés au traitement du cancer du cerveau

Country Status (2)

Country Link
KR (1) KR20120084117A (fr)
WO (1) WO2012099420A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014069689A1 (fr) * 2012-10-31 2014-05-08 주식회사 한국전통의학연구소 Composition pour traiter le cancer rénal et aliment santé fonctionnel contenant un extrait de racine de saussurae
CN114668789A (zh) * 2022-03-23 2022-06-28 昆明理工大学 木香精油在制备治疗脑癌药物或健康产品中的用途

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050055856A (ko) * 2003-12-09 2005-06-14 한국생명공학연구원 코스투놀라이드를 함유하는 에이피-1 저해제

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050055856A (ko) * 2003-12-09 2005-06-14 한국생명공학연구원 코스투놀라이드를 함유하는 에이피-1 저해제

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HEE-RAH OH ET AL.: "The Effects of Saussurea Radix and Plantaginis Herba on Cellular Viability, Proliferation, Apoptosis and Expression of Cell Cycle-related Genes in Gastric Cancer Cells", THE JOURNAL OF KOREAN ORIENTAL ONCOLOGY, vol. 7, no. 1, 2001, pages 1 - 18 *
HYUN-SUN PARK ET AL.: "Sesquiterpene Lactones from Saussurea lappa and Their Cell Proliferaion Effects on Human Breast Cell Lines", YAKHAK HOEJI, vol. 51, no. 2, 2007, pages 145 - 149 *
SO-YOUNG PARK ET AL.: "Inhibitory Effect of the Hexane Extract of Saussurea lappa on the Growth of LNCaP Human Prostate Cancer Cells", JOURNAL OF THE KOREAN SOCIETY OF FOOD SCIENCE AND NUTRITION, vol. 37, no. 1, 2008, pages 8 - 15 *

Also Published As

Publication number Publication date
WO2012099420A2 (fr) 2012-07-26
KR20120084117A (ko) 2012-07-27

Similar Documents

Publication Publication Date Title
NZ628294A (en) Compositions and methods of use of phorbol esters for the treatment of stroke
WO2012157978A3 (fr) Extraits de daphne genkwa, et composition pharmaceutique contenant des fractions desdits extraits ou des composés séparés desdits extraits en tant que principes actifs, dans la prévention ou le traitement de la dermatite atopique
PH12014501967A1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
MY181602A (en) Isochromene derivatives as phosphoinositide 3-kinases inhibitors
PH12012500773A1 (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
MX381044B (es) Composición que contiene extracto o fracción de plantas del género justicia.
TN2015000255A1 (fr) Chitine ou ses derives pour la prevention et/ou le traitement de parasitoses
WO2011159129A3 (fr) Nouveaux dérivés de rhodanine, procédé pour les préparer et composition pharmaceutique pour la prévention ou le traitement du sida contenant les dérivés de rhodanine comme principes actifs
WO2011149301A3 (fr) Composition comprenant l'extrait de physalis alkekengi var. francheti hort en tant que principe actif pour la prévention et le traitement de maladies inflammatoires
WO2012134169A3 (fr) Composition pour le traitement du cancer du poumon et aliment fonctionnel contenant un extrait de semence de gleditsiae
WO2012108749A3 (fr) Composition et alimentation fonctionnelle pour traiter le cancer du cerveau comprenant un extrait de graines de pharbitis
PH12013502563A1 (en) Dha and epa in the reduction of oxidative stress
WO2011118957A3 (fr) Composition destinée à traiter les maladies inflammatoires, allergiques ou asthmatiques contenant des extraits de paprika
WO2012108748A3 (fr) Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait d'albizzia julibrissin
WO2012099420A3 (fr) Composition et aliment fonctionnel comprenant des extraits d'élécampane et destinés au traitement du cancer du cerveau
HK1201189A1 (en) Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections
WO2012099419A3 (fr) Composition et aliment fonctionnel comprenant des extraits de cirsium japonicum et destinés au traitement du cancer du cerveau
WO2012108747A3 (fr) Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait de la racine d'helena
WO2012099424A3 (fr) Composition et aliment naturel fonctionnel comprenant des extraits de fenugrec utilisés dans le traitement du cancer du cerveau
WO2012108744A3 (fr) Composition et alimentation fonctionnelle pour traiter le cancer du cerveau comprenant un extrait de la fleur inula
WO2012108745A3 (fr) Composition et alimentation fonctionnelle pour traiter le cancer du cerveau comprenant un extrait de gleditsiae semen
WO2012134252A3 (fr) Composition pour le traitement du cancer du rein et aliment fonctionnel contenant un extrait de semence de cannabis
WO2012108746A3 (fr) Composition et composition cosmétique pour traiter le cancer du cerveau comprenant un extrait de racine de rubia cordifolia
WO2012099422A3 (fr) Composition et aliment naturel fonctionnel comprenant des extraits de lysimachiae foenum-graeci herba utilisés dans le traitement du cancer du cerveau
WO2013038200A3 (fr) Troubles neurodéveloppementaux

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12736828

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12736828

Country of ref document: EP

Kind code of ref document: A2